|
 |
| home > pmps > summer 2004 > in sailing to utopia: a revolutionary new phase for the pharmaceutical cold chain shipping scene |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
New materials are currently being introduced that will radically improve the design efficiency of contemporary validated temperature controlled shippers for pharmaceutical products. They will also have the potential to extend the principle of validated shipping to product types hitherto excluded, particularly those that require warm as opposed to chilled or frozen shipping solutions.
This article will discuss these new materials including the applications for which they are suitable, and their various advantages and disadvantages. The new generation of materials all have one thing in common: they are phase change materials or PCMs. As most readers will appreciate, there is no secret about PCMs: in fact anybody who is using temperature-controlled packaging (TCP) is already used to the concept - dry ice, 00C water-based gel or cool packs all qualify.
This is because PCMs are simply materials that absorb or release large amounts of heat energy whilst changing phase - latent heat capacity. This happens when solids turn to liquids, liquids turn to solids or some other similar phase change happens. As water absorbs and releases a comparatively large amount of latent heat energy, it raises no safety issues in respect of either transportation or disposal and is widely available. It also makes an excellent material for the purpose of keeping products at chilled temperatures. Indeed, 00C water-based materials in the form of gel-packs or cool-packs are widely used as PCMs in +20C to +80C shippers. This is the temperature range for most pharmaceutical products that require cold chain distribution.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
FT Global Pharmaceutical and Biotechnology Conference 2008
2-3 December 2008, The Cumberland, London
FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
|
